NCT06316037

Brief Summary

The ADAPTAWORK\_2 study is a follow-up to the first qualitative study, to evaluate the feelings of hospital workers in all occupations about teleworking. This involves measuring the variation between three periods: before the COVID-19 pandemic, during the first lockdown an after the pandemic. Secondary objectives were: 1) to evaluate wich factors were associated to the feelings towards teleworking, 2) to assess musculo-squeletal disorders among teleworkers and the other participants, 3) to assess psycho-social risks among teleworkers and the oher participants, and 4) to evaluate teleworking costs

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
945

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 12, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 20, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 20, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 6, 2024

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 18, 2024

Completed
Last Updated

March 18, 2024

Status Verified

March 1, 2024

Enrollment Period

4 months

First QC Date

March 6, 2024

Last Update Submit

March 15, 2024

Conditions

Keywords

Teleworkingworking at home

Outcome Measures

Primary Outcomes (1)

  • Feeling about teleworking

    visual analogic scale (VAS), from 0 (very bad feeling) to 100 (very good feeling) scale

    Period 1 of questionnaire= from March 17, 2019 to March 17, 2020; Period 2=from March 18, 2020 to January 18, 2021; Period 3= from January 19, 2021 to January 20, 2024 (study end date).

Secondary Outcomes (3)

  • Musculo-squeletic pain

    Period 3= from January 19, 2021 to January 20, 2024 (study end date).

  • psychosocial risks

    Period 3= from January 19, 2021 to January 20, 2024 (study end date).

  • purchases

    Period 1 of questionnaire= from March 17, 2019 to March 17, 2020; Period 2=from March 18, 2020 to January 18, 2021; Period 3= from January 19, 2021 to January 20, 2024 (study end date).

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Hospital workers

You may qualify if:

  • all hospital workers in the University Hospital Centre of Clermont-Ferrand, and the hospitals belonging to the same HTG who agreed to participate and complete the questionnaire, regardless of their function or grade in the work establishment

You may not qualify if:

  • N/A

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Clermont-Ferrand

Clermont-Ferrand, France

Location

MeSH Terms

Conditions

Occupational Stress

Condition Hierarchy (Ancestors)

Occupational DiseasesStress, PsychologicalBehavioral SymptomsBehavior

Study Officials

  • Frédéric Dutheil

    University Hospital, Clermont-Ferrand

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 6, 2024

First Posted

March 18, 2024

Study Start

September 12, 2023

Primary Completion

January 20, 2024

Study Completion

January 20, 2024

Last Updated

March 18, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

It was not planned to share participants' IDs, which only the investigator is able to know.

Locations